Asthma drug benralizumab put to the test in everyday life

NCT ID NCT05603845

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well benralizumab (Fasenra) works for people with severe eosinophilic asthma in real-world clinics across the Gulf, Latin America, and India. Researchers tracked 291 patients to see if their asthma control improved over time using a standard questionnaire. The goal was to provide practical evidence on how the drug performs outside of strict clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: benralizumab (Fasenra)
What this could lead to: If successful, this could confirm that benralizumab helps patients with severe eosinophilic asthma achieve better day-to-day control of their symptoms.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new treatment, only how an existing one works in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma pulmonary eosinophilia T2-high asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEVERE ASTHMA

Contacts and locations

Show contact details

Locations

Research Site

Bogotá, Colombia
Research Site

Bucaramanga, Colombia
Research Site

Ibague, Colombia
Research Site

Pereira, Colombia
Research Site

Santiago de los Caballeros, Dominican Republic
Research Site

Santo Domingo, Dominican Republic
Research Site

Ahmedabad, India
Research Site

Ajmer, India
Research Site

Chennai, India
Research Site

Delhi, India
Research Site

Hyderabad, India
Research Site

Jaipur, India
Research Site

Kolkata, India
Research Site

Pune, India
Research Site

Secundrabad, India
Research Site

Vadodara, India
Research Site

Sabah Al Salem, Kuwait
Research Site

Muscat, Oman
Research Site

Doha, Qatar
Research Site

Jeddah, Saudi Arabia
Research Site

Riyadh, Saudi Arabia
Research Site

Abu Dhabi, United Arab Emirates
Research Site

Al Ain City, United Arab Emirates
Research Site

Dubai, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.